setipafant has been researched along with Shock, Septic in 1 studies
*Shock, Septic: Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guinot, P | 1 |
1 review(s) available for setipafant and Shock, Septic
| Article | Year |
|---|---|
Clinical experience with platelet-activating factor antagonists. Past, present, and near future.
Topics: Animals; Azepines; Clinical Trials as Topic; Graft Rejection; Humans; Kidney Transplantation; Lactones; Plant Extracts; Platelet Activating Factor; Randomized Controlled Trials as Topic; Shock, Septic; Thienopyridines; Triazoles | 1994 |